5. Duke professor-led biotech company raises $175 million to advance epigenome editing therapy clinical trials
Srilakshmi Venkatesan/The (Duke) Chronicle Tune Therapeutics, a Durham biotechnology startup co-founded by a Duke professor, announced the completion of its Series B fundraising round on Jan. 12, in which it raised $175 million to support clinical trials for its epigenome editor. The company will use the funding to advance clinical...
February 2, 2025